Abattis Bioceuticals Corp. announced the appointment of Dr. William Panenka to the Board of Directors. Dr. Panenka is currently a co-investigator on several clinical studies involving Cannabis, focusing on the effects of THC and CBD on psychosis, mood and anxiety. In collaboration with a local biotech start-up company, his team at UBC was recently awarded a MITACS industry-academic partnership grant to partially fund this research.